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Abstract  
Objective 
The illness perceptions of the relatives of patients with functional neurological symptom 
disorders (FNSD) ĂŶĚƚŚĞƌĞůĂƚŝŽŶƚŽƉĂƚŝĞŶƚƐ ?ŝůůŶĞƐƐƉĞƌĐĞƉƚŝŽŶƐhave been little studied. 
We aimed to compare illness perceptions of relatives of patients with FNSD to those held by 
patients themselves. We used control pairs with neurological diseases (ND) to examine the 
specificity of the findings to FNSD. 
 
Material and methods 
Patients with FNSD (functional limb weakness and psychogenic non-epileptic seizures) and 
patients with ND causing limb weakness and epilepsy, and their relatives, completed 
adapted versions of the Illness Perception Questionnaire Revised (IPQ-R).  
 
Results 
We included 112 pairs of patients with FNSD and their relatives and 680 ND patient and 
relative pairs. Relatives of patients with FNSD were more likely to endorse psychological 
explanations and, in particular stress as a causal factor than patients with FNSD (p <.001). 
Relatives of FNSD patients were also more pessimistic about the expected duration of the 
disorder and perceived a greater emotional impact than patients themselves (p <.001). 
However, the latter two differences between patients and relatives were also found in ND 
pairs. 
 
Conclusion 
The main difference in illness perceptions between relatives and patients with FNSD was a 
tendency for relatives to see psychological factors as more relevant than patients. Some 
oOther differences were observed between FNSD relatives and patients but the same 
differences were also seen in ND pairs. These other differences were therefore not  and are 
therefore not specific to FNSD. Discussion about possibly relevant psychological factors with 
patients suffering from FNSD may be helped by including relatives.  
Introduction 
 
It has long been argued that illness perceptions have a central role in the aetiology of 
functional neurological symptom disorders (FNSD) [1]. Studies in psychogenic nonepileptic 
seizures (PNES) and functional weakness have demonstrated that patients generally have 
illness perceptions compatible with behaving and feeling as if they have the corresponding 
neurological disease [2-6]. Illness perceptions can arise or alter because be seen both as a 
patient has experienced consequence of a baffling, frightening and unexpected neurological 
symptom. However, by helping to but also as a factor which may be relevant in the 
processes which determine whether somatic sensations are noticed and recognised as 
symptoms illness perceptions may also be aetiologically relevant: attention to particular 
sensations is likely  ? at least in part - ƚŽďĞĚƌŝǀĞŶďǇƉĞŽƉůĞ ?ƐƉƌŝŽƌďĞůŝĞĨs about medical 
disorders and the functioning of the body.  
 
Illness perceptions are also likely to be relevant for patients with recognised neurological 
disease (ND) and may help to ĞǆƉůĂŝŶĐůŝŶŝĐĂůůǇŝŵƉŽƌƚĂŶƚĨĞĂƚƵƌĞƐƐƵĐŚĂƐƉĂƚŝĞŶƚƐ ?ůĞǀĞůŽĨ
disability or health related quality of life [7-10].  
 
In patients with FNSD ƉĂƚŝĞŶƚƐ ?illness perceptions are likely to have very significant effects 
on ƚŚĞŝƌĂĐĐĞƉƚĂŶĐĞŽĨƉƐǇĐŚŽůŽŐŝĐĂůƚƌĞĂƚŵĞŶƚƐĂŶĚŽŶƉĂƚŝĞŶƚƐ ?ŽƵƚĐŽŵĞbe central to the 
provision of clinical care. PPatients with PNES for instance are more likely than those with 
epilepsy to consider their problem "somatic" rather than "psychological", or to deny 
significant non-health stresses in their lives [3]. Similarly patients with functional weakness 
are less likely to agree that stress was a cause of their symptoms than those with weakness 
caused by neurological disease (24% vs 56%) [4]. These observations suggest that illness 
perceptions are likely to be one of the reasons why patients with FNSD may find it difficult to 
can stand in the way of successful engagement in psychological treatment [11], although a 
number of studies have shown that such treatment can be effective [12-13].  
 
In patients with FNSD, illness perceptions have also been linked to outcomes; Sharpe et al. 
[14] showed that FNSD illness perceptions, especially beliefs in non-recovery and a somatic 
cause of symptoms, played a more important role in poor prognosis than other variables 
such as anxiety, depression and even physical functioning.  
 
/ƚŝƐůŝŬĞůǇƚŚĂƚƉĂƚŝĞŶƚƐ ?ŝůůŶĞƐƐƉĞƌĐĞƉƚŝŽŶƐĂƌĞŶŽƚŽŶůǇƐŚĂƉĞĚĂŶĚŝŶĨůƵĞŶĐĞĚďǇƚŚĞŝƌ
knowledge of the body and its disorders and their encounters with doctors, but also by their 
interactions with family, friends and caregivers. The authors of this paper have encountered 
many cClinical situtations in which caregivers were characterised as ians often recall 
 “ŽǀĞƌďĞĂƌŝŶŐ ? ? “ŽǀĞƌ-ŝŶǀŽůǀĞĚ ?Žƌ “ĐŽ-ĚĞƉĞŶĚĞŶƚ ?, and  relatives ĂƐĞŶŚĂŶĐŝŶŐƉĂƚŝĞŶƚƐ ?
disabilities. As long ago as 1892 Gowers commented in his textbook of neurology, "The near 
relatives of the hysterical are often conspicuously deficient in judgment, and the little 
common sense they may possess is often rendered useless by their affection for the 
sufferers" [15]. However, these stereotypes of illness perceptions in relatives of patients with 
FNSD have been little studied empirically. Nor have they been compared to those found in 
relatives of patients with ND. Morgan et al. [16] examined how the parents of children with 
seizures perceived PNES terminology and how this would affect their trust in the doctor. 
Other studies have examined family functioning or determinants of the quality of life of 
caregivers for people with  epilepsy and PNES, but have not studies  their perceptions about 
what was wrong [17-20]. Family members ? perceptions of the causes of FNSD may be 
particularly relevant and may affect which treatments patients choose. For instance, in 
another field, Dardennes et al. [21] found that parental perceptions about the causes of 
autism affected their choice of therapy type. 
 
The Illness Perception Questionnaire-Revised (IPQ-R) has been used to compare the illness 
perceptions of the relatives of, and patients with, a range of conditions [22]. The IPQ-R is 
based on the self-regulation model, which proposes that the way in which people behave in 
relation to illness depends on their perception or mental representation of their health 
problem. This model subdivides illness representations into five elements: identity 
(symptoms), cause, consequences (effects on life), timeline (duration) and controllability or 
cure [23]. The IPQ-ZĂůƐŽĂƐƐĞƐƐĞƐƉĞŽƉůĞ ?ƐƉĞƌĐĞŝǀĞĚƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨƚŚĞŚĞĂůƚŚƉƌŽďůĞŵ
(coherence) and the emotional impact of the health problem (emotional representations).  
 
The illness perceptions of patients and their partners have been related to quality of life in 
,ƵŶƚŝŶŐƚŽŶ ?ƐĚŝƐĞĂƐĞ[24], coping and adaptive outcome in chronic fatigue syndrome and 
ĚĚŝƐŽŶ ?ƐĚŝƐĞĂƐĞ[25-26], recovery following myocardial infarction [27] and psychological 
adjustment in rheumatoid arthritis [28]. Overall, these studies have indicated that ƌĞůĂƚŝǀĞƐ ?
illness perceptions are relevant to ƉĂƚŝĞŶƚƐ ?psychological outcomes. Depending on the 
clinical scenario, both contrasting and concordant perceptions in couples have been related 
to better patient adjustment [24]. Other studies have focused more on the relevance of 
ƌĞůĂƚŝǀĞƐ ?ŝůůŶĞƐƐƉĞƌĐĞƉƚŝŽŶƐƚŽƚŚĞĞǆƉĞƌŝĞŶĐĞŽĨƚŚĞƌĞůĂƚŝǀĞ ?ƐƚƵĚǇŽĨĨĂŵŝůǇĐĂƌĞƌƐŽĨ
individuals with eating disorders found that carers were less likely to view their caregiving 
ƉŽƐŝƚŝǀĞůǇŝĨƚŚĞǇďĞůŝĞǀĞĚƚŚĞŝůůŶĞƐƐǁĂƐĂƚƚƌŝďƵƚĂďůĞƚŽƚŚĞƉĂƚŝĞŶƚ ?ƐƉĞƌƐŽŶĂůŝƚǇ[29]. A 
recent paper comparing caregivers of patients with epilepsy with caregivers of patients with 
PNES found no difference in caregiver quality of life; however, differences in illness 
perceptions were not measured [19]. In fact, there have been no studies of relatives ? illness 
perceptions in FNSD such as PNES or functional weakness. However, clinical experience 
suggests that it is of vital importance to engage not only patients with FNSD with the 
rationale for diagnosis and treatment, but also their relatives and friends [30].  
 
The aim of this study was firstly to compare the illness perceptions of patients and their 
relatives and friends with FNSD and secondly to do the same in patients and their relatives 
and friends with ND, to determine the specificity of any differences found between the FNSD 
patient-relative pairs.  
 
Method 
 
Recruitment of the weakness groups 
Patients with functional weakness and weakness due to ND were recruited prospectively by 
consultant neurologists working at the Department of Clinical Neurosciences, Western 
General Hospital in Edinburgh between 1999 and 2002. The study was promoted by means 
of personal contact and reminders and through regular newsletters. Patients with an 
unequivocal functional limb weakness with no neurological disease comorbidity and onset 
within two years were referred to the study by consultant neurologists who had made the 
diagnosis. Patients with weakness caused exclusively by a neurological disease, with 
symptom onset within two years were identified consecutively and prospectively from the 
inpatient and outpatient correspondence of three consultant neurologists. Patients aged 
under 16 or with communication difficulties preventing the completion of the questionnaire 
were excluded. JS carried out a research assessment of participants following which they 
were asked to give the IPQ-R to a relative or friend who they thought had been involved in 
their illness. They were provided with a stamped addressed envelope to return it. Further 
details of recruitment and other clinical and self-report data from the weakness patient 
groups, including the patient IPQ-R results (but not their relatives), have been reported 
previously [4,31]. 
 
Recruitment of the seizure disorder groups 
Between May 2009 and December 2011, KW reviewed all EEG request forms submitted to 
the Clinical Neurophysiology department of the Royal Hallamshire Hospital in Sheffield. We 
prospectively identified all patients referred for video-EEG (outpatient routine or two to five 
day videotelemetry) with a differential diagnosis of epilepsy or PNES. Patients aged under 16 
or with communication difficulties preventing completion of the questionnaire were 
excluded. Two weeks prior to their attendance for the test we sent potential participants 
information about the study. This included a relative study pack containing the adapted IPQ-
R and a self-addressed envelope which the patient could choose to pass on to a relative or 
friend if they wished to take part in the study. Patients were asked whether they wanted to 
participate and completed their questionnaires at the hospital when they attended for their 
EEG appointment. 
 
Patients' ĂŶĚƚŚĞŝƌƌĞůĂƚŝǀĞ ?ƐƋƵĞƐƚŝŽŶŶĂŝƌĞƌĞƐƉŽŶƐĞƐǁĞƌĞŽŶůǇŝŶĐůƵĚĞĚŝŶƚŚĞĂŶĂůǇƐŝƐŝĨĂ
"gold standard" diagnosis had been made, i.e. if an attack considered typical by the patient 
and family members (if available) was recorded, if the recorded attack was judged to be 
clearly epileptic or non-epileptic by a Consultant Neurophysiologist, and if the referring 
neurologist confirmed that the recorded seizure matched the final diagnosis of epilepsy or 
PNES based on the video-EEG report and all other available clinical data. Patients with mixed 
epilepsy and PNES were excluded. We have used the data provided by this patient group 
(but not their relatives) in a previous study comparing the perceptions of seizure patients 
with those of neurologists [2]. 
 
Illness perception questionnaire-revised (IPQ-R) 
The IPQ-R is a 38-item self-ƌĞƉŽƌƚƋƵĞƐƚŝŽŶŶĂŝƌĞĚĞƐŝŐŶĞĚƚŽĐĂƉƚƵƌĞƚŚĞŶĂƚƵƌĞŽĨƉĂƚŝĞŶƚƐ ?
illness perceptions [22]. The questionnaire asks respondents to rate each item on a 5-point 
Likert scale (ranging from "I strongly agree" to "I strongly disagree"). It generates eight 
different subscales (subscales used within this study ůŝƐƚĞĚǁŝƚŚƚŚĞƌŽŶďĂĐŚ ?ƐĂůƉŚĂ
coefficient for the patients and relatives/friends respectively): Timeline (acute/chronic) (.878 
and .908); Consequences (.784 and .769); Personal control (.812 and .790); Treatment 
control (.746 and .828); Timeline (cyclical) (.809 and .804); Emotional representations (.862 
and .870). Two subscales from the IPQ-R were not used. The coherence subscale was 
excluded because perceptions about understanding of a condition will be affected by what 
stage of diagnosis patients are at so it did not make sense to use this with combined groups. 
The identity subscale was excluded because it is a list of general symptoms which are not 
particularly relevant to the conditions of our patient groups. The IPQ-R also encourages 
respondents to rate items from a list of 18 possible causes for the described disorder on the 
same Likert scale. These causes can be grouped into psychological/emotional (cause items 1, 
9 ?12, 17) and non-psychological (cause items 2 ?8, 13 ?16, 18) (See Table 2). The 
ƉƐǇĐŚŽůŽŐŝĐĂůŐƌŽƵƉŝŶŐŽĨƚŚĞĐĂƵƐĂůĚĂƚĂŝƐƵƐĞĚǁŝƚŚŝŶƚŚŝƐƐƚƵĚǇĂŶĚŚĂƐĂƌŽŶďĂĐŚ ?Ɛ
alpha coefficient of .864 for patients and .846 for relatives.  The IPQ-R has been shown to 
have good levels of both internal consistency and test ?retest reliability in patients with a 
wide range of different conditions [22]. The IPQ-R is an improved version of the Illness 
Perception Questionnaire (IPQ) [32]. The IPQ and IPQ-R have been used in a number of 
studies regarding epilepsy or PNES [2,9,8,33-34,].  
 
A relative's version of the IPQ-R followed exactly the same structure but with a slightly 
altered wording so that the respondent is being asked about their "relative or friend's 
illness" rather than their own. ^ŝŶĐĞƚŚŝƐƐƚƵĚǇ ?ƐĚĂƚĂǁĂƐĐŽůůĞĐƚĞĚ ?ĂƐƉŽƵƐĞǀĞƌƐŝŽŶŽĨƚŚĞ
IPQ-R (excluding the cause subscale) for husbands of women with rheumatoid arthritis has 
been developed and shown to be reliable and have a predictive validity over a four-month 
period [35]. Within this study, the scoring system for each subscale was normalised so that 
each score ranged from 0-100 as described in Table 2.  
 
Hospital Anxiety and Depression Scale (HADS) 
All patient groups also completed the Hospital Anxiety and Depression Scale (HADS) [36], 
which is an established, valid and reliable measure of severity of depression and anxiety in 
non-psychiatric clinical environments. It consists of 14 items, seven of which measure 
depression and seven anxiety. Scores range from 0 to 21 for anxiety and 0 to 21 for 
depression. A score of 11 or higher indicates probable presence of the mood disorder 
('caseness'). It has been widely used in studies of patients with neurological diseases and in 
functional disorders [37]. 
 
Statistical analysis 
For this study the functional weakness and nonepileptic seizure patients and their relatives 
were combined to form one Functional Neurological Symptom Disorder (FNSD) group and a 
FNSD relative group. Likewise, the patient groups with epilepsy and weakness explained by 
neurological disease were combined to form one ND group and a paired ND relative group. 
 
We sought to investigate the differences or similarities of the perceptions of the patient-
relative pairs only. In this analysis we did not compare patient group means with each other 
or the relative groups with each other. The internal consistency of the IPQ-R subscales used 
ǁĂƐĂŶĂůǇƐĞĚďǇĐĂůĐƵůĂƚŝŶŐƌŽŶďĂĐŚ ?ƐɲƐĐŽƌĞƐ ?ƌŽŶďĂĐŚ ?ƐɲA? ? ? ?ǁĂƐĐŽŶƐŝĚĞƌĞĚ
acceptable. Means and standard deviations were calculated for each subscale score and 
paired t-tests were used to make comparisons between patients with the disorder and their 
relatives.  We wished to compare the FNSD and ND pairings directly so we conducted 
additional ANCOVA analyses to look at interaction between the key issues: patients vs. 
relatives and FNSD vs. ND (controlling for patient group, seizure vs. weakness).  Two 
subscales from the IPQ-R were not used. The coherence subscale was excluded because 
perceptions about understanding of a condition will be affected by what stage of diagnosis 
patients are at so it did not make sense to use this with combined groups. The identity 
subscale was excluded because it is a list of general symptoms which are not particularly 
relevant to the conditions of our patient groups.  ‘^ƚƌĞƐƐŽƌǁŽƌƌǇ ?ǁĂƐƉƌŽǀŝĚĞĚĂƐŽŶĞŽĨƚŚĞ
possible causes for the condition within the IPQ-R and this was analysed as a single item. 
Due to making multiple comparisons, we conservatively interpreted two-sided P values of 
A? ? ? ? ? as significant. 
 
Ethical approval 
Ethical approval for the weakness part of the study was provided by the Lothian Research 
Ethics committee. Ethical approval for the seizure disorder arm of the study was provided by 
the Sheffield Research Ethics Committee.  
 
Results 
Participants 
We recruited 107 patients with functional weakness (and 92 of their relatives and friends) 
and 46 patients with weakness caused by neurological disease (and 40 of their relatives and 
friends). We recruited 40 patients with PNES (and 20 of their relatives and friends) and 34 
patients with epilepsy (and 20 of their relatives and friends) (Table 1). Because there were 
only 11 'friends' among the 172  ‘relatives and friends ? we refer to them from this point on as 
'relatives' for the sake of simplicity. In the FNSD patient group there were no significant 
differences between the gender, age, duration of symptoms and anxiety and depression 
score of patients with relative IPQ data (n=172) and those without (n=55). In the ND patients 
there were no significant differences except that participants who had recruitedrs a relative 
had a significantly shorter duration of symptoms than those who had notnon-recruiters 
(median 19 months vs. 78 months respectively; Mann-Whitney U test gives p = .015; U = 
414.5). 
 
The paired data from the four subgroups was investigated separately to ensure that creating 
combined FNSD and ND groups was appropriate. Data from the subgroups were combined 
into one FNSD and one ND group when we had established that all significant dyadic 
differences on the IPQ-R subscales in the functional weakness plus PNES and in the 
neurological weakness plus epilepsy groups were in the same direction. 
 Internal reliability of the IPQ-R subscales 
The internal reliability of all IPQ-R subscales was satisfactory or good. ůůƌŽŶďĂĐŚ ?ƐĂůƉŚĂ
coefficients were greater than 0.7 (i.e. well above our acceptability cut-off of 0.6). 
 
Demographic differences 
 
There were no significant differences between the age, gender or anxiety scores of the 
patients with FNSD or ND or the gender of their relatives. The ND patients reported longer 
symptom duration and had lower depression scores than those in the FNSD group.  
 
Patient-relative pair differences 
 
The main results from the study are shown in Table 2. The most striking finding was that 
relatives of patients with FNSD were significantly more likely to endorse psychological causal 
factors such as "stress" than patients. This difference was not found among patients with ND 
and their relatives. 
 
The absolute values in the FNSD patients, however, show that, the relatives of FNSD patients 
as a group still generally disagreed with the idea of  a psychological causation (mean score 
30 out of 100).  
 
There were four subscales which differed in the same direction for both FNSD and ND 
patients suggesting these may be generic effects of asking someone's relative about any 
illness, regardless of its cause. Relatives of both FNSD and ND patients reported that the 
condition caused a greater emotional impact than the patients themselves. There was a 
trend towards both sets of relatives believing in a worse outlook (timeline) and greater 
negative consequences but this only reached statistical significance for FNSD pairs. There 
was also a trend towards both FNSD and ND relatives believing patients had less personal 
control over symptoms than the patients themselves believed but this did not reach 
significance. There were two domains where there were no differences between patients 
and relatives regardless of disorder (treatment control and cyclical nature of the symptoms). 
 
A more detailed analysis of these differences using ANCOVA was conducted to examine the 
interaction between cause (FNSD vs ND) and rater (patient vs relative) on illness perceptions, 
controlling for patient group (seizure vs weakness).  Two cause x rater interactions were 
observed for psychological causes (F = 6.040, p = .015), and stress cause (F = 10.609, p = 
.001) showing that only in FNSD pairs did relatives endorse psychological or stress causes for 
the disorder more than patients (see fig. 1 & 2). This was consistent with the observations 
made from the two separate paired t test comparisons. As shown in table 2, for both 
psychological causes and the stress cause, the diffĞƌĞŶĐĞďĞƚǁĞĞŶƉĂƚŝĞŶƚƐ ?ĂŶĚƌĞůĂƚŝǀĞƐ ?
ratings was significant for FNSD (t = -4.314 and -3.944 respectively, p < .001 for both), but 
non-significant for ND (t= .194 and 1.075 respectively, p > .05 for both).  
 
Discussion 
Although most relatives tended to disagree that FNSD could be due to psychological factors, 
they were significantly less averse to psychological explanations for FNSD (and, in particular, 
stress as a causal factor) than patients with FNSD themselves. This finding was not present in 
the ND pairs. This has important practical implications for clinicians who wish to discuss 
potentially relevant psychological factors  with patients with FNSD [2,38]. Our findings 
suggest that, whilst potentially still requiring persuasion, relatives are more likely to accept 
that FNSD could be linked to stress, emotional problems or coping difficulties. This finding 
goes against the usual stereotype of the 'unhelpful' relative.  
 
Our findings are consistent with a study of 100 patient and 84 witness accounts of non-
epileptic seizures recorded by questionnaire [30]. Although not directly comparable, this 
study found that PNES witnesses perceived a closer link between stress and seizures, as well 
as seizure triggers, than patients themselves. 
 
In both FNSD and ND, wŝƚŚŝŶƐĞǀĞƌĂůĚŽŵĂŝŶƐ ?ƌĞůĂƚŝǀĞƐ ?ŝůůŶess perceptions tended to be 
mŽƌĞŶĞŐĂƚŝǀĞƚŚĂŶƉĂƚŝĞŶƚƐ ? ?This observation could reflect that relatives have a natural 
tendency to be  ‘ĐŽŶĐĞƌŶĞĚ ?ĂŶĚ ‘caring ?. Thus clinicians who pick up on 'overcaring' relatives 
may be doing so primarily because of their own negative cognitive bias and "suspicion" of 
patients with FNSD rather than because of any significant differences to the relatives of 
patients with neurological disease.  Alternatively, the more negative illness perceptions of 
ƌĞůĂƚŝǀĞƐĐŽƵůĚĂůƐŽƌĞĨůĞĐƚĐĂƌĞŐŝǀĞƌƐ ?ĂŶŶŽǇĂŶĐĞĂŶĚĨƌƵƐƚƌĂƚŝŽŶ or their anxiety about the 
ƉĂƚŝĞŶƚƐ ?ĚŝƐŽƌĚĞƌ. Potentially, caregivers with such negative attitudes could discourage 
patients from achieving maximum independence despite their health problems. However, 
given that caregivers in both groups (FNSD and ND) had more negative illness perceptions 
than patients this observation cannot readily explain any observations specific to the FNSD 
patient group. 
  
Limitations/future studies 
 
The above conclusions are tempered by a number of study limitations. First, we combined 
ƉĂƚŝĞŶƚƐǁŝƚŚƚǁŽĚŝĨĨĞƌĞŶƚ “ĨƵŶĐƚŝŽŶĂů ?ĂŶĚƚǁŽĚŝĨĨĞƌĞŶƚ “ŶĞƵƌŽůŽŐŝĐĂů ?ƐǇŵƉƚŽŵƐĨŽƌƚŚĞ
analyses in this study. Weakness and seizures are different problems  ? weakness is more 
persistent, seizures come and go  ? analysis of the subgroups separately showed that 
significant paired differences were common to both of the subgroups making up an overall 
condition. It is uncertain how much heterogeneity this may be disguising and whether the 
data can be generalized to patients with milder FNSD or other functional symptoms.  
Second, we did not have much information about the relatives who took part in the study. It 
may be that further data about them such as the nature of their relationship with the 
patient or how long they had known the individual may influence their views. Third, when 
presenting illness perceptions of patients in isolation it is also important to consider the 
context of those perceptions and where some of them may have originated from. For 
example, studies of neurologists, nurses and physiotherapists show that a minority harbour 
very negative views about patients with functional disorders which may significantly affect 
the views of patients and relatives [34,39].  Fourth, the cross-sectional design of our study 
does not allow us to distinguish between illness perceptions resulting from the experience of 
the symptoms and illness perceptions predating their onset and, perhaps, contributing to 
their development. Finally, the use of statistical averaging may hide clinically relevant 
heterogeneity among the patients and their relatives. For example, although on average 
relatives are more willing to consider psychological explanations in FNSD it may be that 
there are subgroups that are much less willing to do this than the patient. This would be 
clinically relevant for a particular patient-relative pair.  
 
Notwithstanding these limitations, we found  that the relatives of patients with FNSD are 
more likely to contemplate an aetiological role of psychological factors or stress than 
patients themselves, implying that they may have a positive role to play when encouraging 
patients to accept that psychological factors are relevant to their symptoms. Other potential 
differences in illness perceptions between patients and their relatives appear to be generic 
and not specific to FNSD ĐĂůůŝŶŐƚŚĞƌĞůĞǀĂŶĐĞŽĨƉŚĞŶŽŵĞŶĂƐƵĐŚĂƐ ‘ƚŚĞŽǀĞƌ-caring 
ƌĞůĂƚŝǀĞ ?ŝŶƚŽƋƵĞƐƚŝŽŶ. Future longitudinal studies could focus on whether differences in 
perceptions of patients and their relatives and have effects on medical or social outcomes 
and whether the effect of differences in illness perceptions is the same in patients with FNSD 
and patients with ND. 
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